Suspected side effects from any medicine, including unlicensed compounds, should be reported to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk
The effects of the BCATi on measured metabolites in each compartment, compared with untreated Mmut p.L690Ins/p.L690Ins mice, are indicated in blue (normal), green (increased), or red (decreased)
Notably, DKA risk increased with higher SGLT2i doses and was modified by various factors including BMI and insulin resistance
Vivar KL, Deschaine M, Messina J, Divine JM, Rabionet A, Patel N, Harrington MA, Seminario-Vidal L (2017) Epidermal programmed cell death-ligand 1 expression in TEN associated with nivolumab therapy